Sanofi (SNYNF) EBT (2009 - 2026)

Sanofi (SNYNF) has 18 years of EBT data on file, last reported at $14.6 billion in Q1 2026.

• Quarterly EBT rose 15.1% year-over-year to $14.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $88.0 billion (up 32.2% YoY) and the FY2025 annual result came in at $7.2 billion, changed 0.43% from the prior year.
• EBT advanced to $14.6 billion in Q1 2026 per SNYNF's latest filing, from $14.1 billion in the prior quarter.
• The five-year high for EBT was $53.8 billion in Q4 2023, with the low at $12.4 billion in Q1 2024.
• Average EBT over 5 years is $18.8 billion, with a median of $14.1 billion recorded in 2025.
• Year-over-year, EBT soared 107860.81% in 2022 and plunged 51.49% in 2024.
• Sanofi's EBT stood at $18.0 billion in 2022, then surged by 198.73% to $53.8 billion in 2023, then sank by 51.49% to $26.1 billion in 2024, then sank by 46.11% to $14.1 billion in 2025, then gained by 3.92% to $14.6 billion in 2026.
• Business Quant data shows SNYNF's EBT at $14.6 billion in Q1 2026, $14.1 billion in Q4 2025, and $45.3 billion in Q3 2025.